Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Qingkong Jinxin Blue Microbiology Fund



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
The average size of a deal this fund participated in
Portfolio companies 2
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care

We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Zhiyi Pharmaceutics

The important activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 5 - 10 millions dollars.

The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Shenzhen Capital Group, Shangdong Meiyu.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Atlantic Ventures Germany, Hessen, Kassel
Berkshire Group Boston, Massachusetts, United States
CIMB Kuala Lumpur, Malaysia
Explore Ventures -
Guokai Ronghua -
Hengying Capital Beijing, Beijing, China
Impact Venture England, London, United Kingdom
Instarto Central, Central Region, Singapore
Irish Venture Capital Association County Wicklow, Ireland, Wicklow
LUMO labs Eindhoven, Noord-Brabant, The Netherlands
MIAX Exchange Group New Jersey, Princeton, United States
Nanjing Bangsheng Touzi China, Jiangsu, Nanjing
Pfeffer Capital -
Provenio Capital California, Newport Beach, United States
Prudence Holdings New York, New York, United States
RPS Ventures California, Palo Alto, United States
Safer Made Connecticut, New Haven, United States
Scorpion Capital Partners New York, New York, United States
The Rahn Group Minneapolis, Minnesota, United States
U.S. Army Combat Capabilities Development Command Army Research Laboratory Louisiana, Maryland, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Health Care
$15M18 Feb 2020 Shandong

Zhiyi Pharmaceutics

$7M05 Sep 2018 Guangdong Province


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Qingkong Jinxin Blue Microbiology Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 11M
Peak activity year 2018
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Health Care
$15M18 Feb 2020 Shandong

Zhiyi Pharmaceutics

$7M05 Sep 2018 Guangdong Province
Crunchbase icon

Content report

The following text will be sent to our editors: